# Phase 2 Trial for Chemo-Resistant Gestational Trophoblastic Neoplasias With Pembrolizumab (CR-GTP)

> **NCT04303884** · PHASE2 · UNKNOWN · sponsor: **CHA University** · enrollment: 15 (estimated)

## Conditions studied

- Gestational Trophoblastic Neoplasia

## Interventions

- **DRUG:** Pembrolizumab Injection [Keytruda]

## Key facts

- **NCT ID:** NCT04303884
- **Lead sponsor:** CHA University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2020-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04303884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04303884, "Phase 2 Trial for Chemo-Resistant Gestational Trophoblastic Neoplasias With Pembrolizumab (CR-GTP)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04303884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*